Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A: Each glass vial contains 10 ml and is shipped in boxes of 25 vials
Plasmapheresis has been studied for over 50 years
And pharmaceutical companies don't want to spend millions of dollars on drug trials unless they own the intellectual property
In rare cases, high doses of B12 might exacerbate anxiety symptoms due to fluctuations in energy levels
Blend Composition BPC-157 Gastric Pentadecapeptide 50% TB-500 Thymosin 4 Fragment 50% Reference data BPC-157 + TB-500 Blend specifications Composition BPC-157 + TB-500 (50/50 split) Per-vial amount 5mg + 5mg (10mg) or 10mg + 10mg (20mg) Components Two research peptides Appearance White lyophilized powder Solubility Soluble in bacteriostatic water Purity 99.28% Research applications Where BPC-157 + TB-500 Blend is used in research Areas of study described in the published literature
Published in Pharmaceuticals (PMID: 38675421), this 41-page open-access review proposes that BPC-157, while not meeting classical neurotransmitter criteria, functions as a cytoprotection mediator with neurotransmitter-like activity through a network of interconnected evidence. What Makes BPC-157 Unique BPC-157 is a 15-amino acid peptide (sequence: GEPPPGKPADDAGLV, molecular weight 1419) native and stable in human gastric juice for over 24 hours, showing no sequence homology with known gut peptides
